Results 11 to 20 of about 14,285 (172)
Tobacco Induced Diseases, 2018 Background The FCTC country reports indicate that 70% of the reporting parties have implemented Article 12 in their jurisdictions. The MPOWER Report 2015 also indicates that nearly 40% of the Parties conducted at least one anti-tobacco national mass ...
Amit Yadav +3 more
doaj +1 more source
Global Policy progress in Article 16 of WHO FCTC on cigarettes (CIG) and smokeless tobacco (SLT)
Tobacco Induced Diseases, 2018 Background Article 16 of WHO FCTC focuses upon limiting the supply and exposure of tobacco products to Minors. Implementation of Article 16 has been researched by few local and regional studies, primarily focusing on Cigarettes.
Shekhar Grover +4 more
doaj +1 more source
Implementing effective pricing and taxation measures for prevention and control of smokeless tobacco
Tobacco Induced Diseases, 2018 Background There are approximately 346 million adult smokeless tobacco (SLT) users in the world dominated by the South-East Asian region accounting for nearly 86%. India alone accounts for 67% of the SLT users in the world.
Amit Yadav +4 more
doaj +1 more source
A Model for the Prediction of Tobacco Temperature and Oxygen Profiles in Warehouse Aging Process
Contributions to Tobacco and Nicotine Research, 2007 A mathematical model on the temperature and oxygen profiles for the tobacco warehouse aging process was formulated and solved by numeric analysis. The model parameters were obtained using the non-linear regression method by fitting several years measured
Zheng Y, Chipley J, Dow A, Midgett C
doaj +1 more source
Tobacco Usage and Serum Cotinine: A Hospital Based Study [PDF]
Journal of Clinical and Diagnostic Research, 2019 Introduction: Tobacco usage is mainly in the form of smoking and smokeless tobacco. Some studies commented that smokeless tobacco has high nicotine and toxic effect, but the studies with depictive data have been limited.
Vaishali Satyajeet Pawar +3 more
doaj +1 more source
Tobacco Induced Diseases, 2018 Background Deaths due to tobacco consumption are on the rise, from 5.4 million in 2005 to 6.4 million in 2015 and 8.3 million in 2030 of which more than 80% will be in developing countries. Smokeless tobacco use is a significant cause of disease.
Edao Etu, Desta Gemeda, Mamusha Hussen
doaj +1 more source
Frontiers in Public Health, 2023 IntroductionEvidence on smokeless tobacco use is scarce among indigenous communities, with the available literature based either on a specific tribe or on a particular region. Therefore, we aimed to estimate the prevalence of smokeless tobacco and assess
Ritik Agrawal +6 more
doaj +1 more source
Nicotine and Smokeless Tobacco [PDF]
CA: A Cancer Journal for Clinicians, 1988 The following may be concluded about nicotine and smokeless tobacco use: Systemic absorption and levels of nicotine are similar in users of smokeless tobacco and cigarette smokers. Data from the few studies performed to date suggest that smokeless tobacco users develop a dependency similar to that for cigarette smokers.
openaire +2 more sources
Trends in smokeless tobacco use in the us workforce: 1987-2005
Tobacco Induced Diseases, 2011 The primary aim was to examine whether increasing workplace smoking restrictions have led to an increase in smokeless tobacco use among US workers. Smokeless tobacco exposure increases the risk of oral cavity, esophageal, and pancreatic cancers, and ...
Noella A. Dietz +7 more
doaj +1 more source
Tobacco Induced Diseases, 2017 Introduction Deaths due to tobacco consumption are on the rise, from 5.4 million in 2005 to 6.4 million in 2015 and 8.3 million in 2030 of which more than 80% will be in developing countries.
Edao Sinba Etu +2 more
doaj +1 more source